Top Stories

Johnson & Johnson to begin human trials for coronavirus vaccine in late July, earlier than expected


Alex Gorsky, CEO of Johnson & Johnson

Adam Jeffery | CNBC

Johnson & Johnson announced Wednesday its early-stage human trial for a potential coronavirus vaccine will begin in the second half of July, earlier than its initial forecast of September.

“Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to further accelerate the clinical development of our investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant,” J&J’s Chief Scientific Officer Paul Stoffels said in a press release.

The company began developing a Covid-19 vaccine in January.

It is using the same technologies it used to make its experimental…


ADP private payrolls May 2020 down another 2.76 million

Previous article

IBM, Amazon moves on facial recognition are good baby steps toward removing bias

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories